19-20 November 2020
ANSTO
Australia/Melbourne timezone
Please find the latest version of the UM2020 Program, Poster Presentations & Book of Abstracts at the bottom of the overview page

Cubosomes for the Delivery of Biopharmaceuticals

20 Nov 2020, 10:30
20m
Zoom Meeting Room

Zoom Meeting Room

Oral Chemistry, Catalysis and Soft Matter Session 10 - Chemistry, Catalysis and Soft Matter

Speaker

Charlotte Conn (RMIT)

Description

Biopharmaceuticals, including therapeutic proteins and peptides, represent the fastest growing class of new pharmaceuticals with application as treatments for auto-immune disorders, cancer and cardiovascular disease. Significant efforts have converged towards the design and development of more sophisticated delivery systems for protein-based pharmaceuticals, able to ensure controlled release of these bioactive compounds as well as protect the encapsulated therapeutic from denaturing processes such as enzymatic or acidic hydrolysis. Lipid-based nanomaterials are particularly useful for the encapsulation of amphiphilic proteins and peptides, as their bilayer structure mimics the native cell membrane environment and may assist in retaining the protein in a functionally active form.1 The research presented aims to elucidate the fundamental physicochemical interactions between lipidic nanomaterials, encapsulated proteins and peptides, and cells. In order to screen the large compositional space associated with the design of such materials, we focus on high-throughput methodologies, and the use of large national and international synchrotron facilities such as the Australian Synchrotron, the Bragg Institute and ASTRID2 synchrotron, Denmark. Uptake of cubosomes into eukaryotic cells was shown to be driven by a process of membrane fusion between the lipid bilayer that makes up the nanoparticle and the external cell membrane.2 Synchrotron CD experiments demonstrated that the lipidic cubic phase was able to protect encapsulated insulin against enzymatic degradation by chymotrypsin, which is typically found in the small intestine, over a period of several hours. Finally, the use of lipid nanoparticles as effective delivery vehicles for anti-microbial compounds will be discussed.3
1. Conn, C. E.; Drummond, C. J., Nanostructured Bicontinuous Cubic Lipid Self-Assembly Materials as Matrices for Protein Encapsulation. Soft Matter 2013, 9 (13), 3449-3464.
2. Dyett, B. P.; Yu, H.; Strachan, J.; Drummond, C. J.; Conn, C. E., Fusion dynamics of cubosome nanocarriers with model cell membranes. Nat Commun 2019, 10 (1), 4492.
3. Meikle, T.G.; Dyett, B.; Strachan, J.B.; White, J.; Drummond, C.J. and Conn, C.E. Preparation, Characterization, and antimicrobial activity of cubosome encapsulated metal nanocrystals. ACS Applied Materials & Interfaces 2020, 12 (6), 6944-6954

Primary authors

Dr Brendan Dyett (RMIT) Prof. Calum Drummond (RMIT University) Charlotte Conn (RMIT) Jamie Strachan (RMIT University) Dr Tom Meikle (RMIT)

Presentation Materials

There are no materials yet.
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×